You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple recurrent cardiovascular events

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Disease Trial in Sacramento (device, behavioral, other)

Recruiting
  • Coronary Artery Disease
  • LiveCare
  • +2 more
  • Sacramento, California
    University of California, Davis Medical Center Division of Cardi
Oct 27, 2023

Primary Cardiovascular Events Using the Multimarker Approach

Completed
  • Cardiovascular Diseases
  • +4 more
  • measurement of multiple biomarkers
  • (no location specified)
Jan 19, 2023

A Time to Cardiovascular Event Analysis Comparing Tocilizumab to

Completed
  • Rheumatoid Arthritis
  • (no location specified)
Jan 20, 2023

Cardiovascular Events Among Adults Relapsed or Refractory

Recruiting
  • Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
  • +9 more
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Recurrent Cardiovascular Events in Type 2 Diabetes After PCI

Recruiting
  • Diabetes Mellitus
  • Percutaneous Coronary Intervention
    • Shanghai, China
      Department of Cardiology,Shanghai Tenth People's Hospital
    Nov 22, 2021

    Major Cardiovascular Events in Nonvalvular Atrial Fibrillation

    Completed
    • Atrial Fibrillation
    • Rivaroxaban (Xarelto, BAY59-7939)
    • Multiple Locations, Spain
      (unnamed)
    Jul 15, 2021

    Acute Coronary Syndrome, Lipoprotein Disorder, Acute Myocardial Infarction Trial in Caserta

    Recruiting
    • Acute Coronary Syndrome
    • +3 more
      • Caserta, Italy
        AORN S. Anna e S. Sebastiano
      Aug 9, 2022

      Myocardial Infarction, Acute Coronary Syndrome, Inflammation Trial in Finland (Hydroxychloroquine, Placebo)

      Completed
      • Myocardial Infarction
      • +5 more
      • Helsinki, Finland
      • +5 more
      Jun 6, 2020

      New Echocardiographic Indicators in Treatment of Primary

      Not yet recruiting
      • Multiple Myeloma
      • Chemotherapy and/or autologous hematopoietic stem cell transplantation
      • (no location specified)
      Sep 18, 2023

      Based on CYP2C19 Genotype in Ischemic Stroke

      Active, not recruiting
      • Acute Ischemic Stroke
      • General principles of care and judgement of researcher
      • Yongin-si, Gyeonggi-do, Korea, Republic of
      • +36 more
      Oct 23, 2022

      Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)

      Recruiting
      • Type2Diabetes
      • ASCVD
      • SGLT2 inhibitor
      • +2 more
      • New York, New York
      • +1 more
      Dec 19, 2022

      Myocardial Ischemia and Non Obstructive Coronary Arteries Study

      Recruiting
      • Ischemia With no Obstructive Coronary Artery Disease
      • Data extraction
      • +2 more
      • Rome, Italy
      • +1 more
      Feb 6, 2023

      Long-term Outcome of RIPC After IV Thrombolysis in AIS Patients

      Active, not recruiting
      • Acute Ischemic Stroke
      • functional and medical information
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xian Jiantong University
      Dec 21, 2022

      ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

      Not yet recruiting
      • ASCVD
      • +3 more
      • (no location specified)
      Aug 3, 2023

      Atherosclerosis, Cardiovascular Diseases, Drug Effect Trial (Aspirin)

      Not yet recruiting
      • Atherosclerosis
      • +2 more
      • (no location specified)
      Jul 5, 2023

      Cardiovascular Diseases Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))

      Recruiting
      • Cardiovascular Diseases
      • Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
      • Nassau, The Bahamas, Bahamas
        The Partners Clinical Research Centre at The Medical Pavilion
      Oct 17, 2023

      Coronary Artery Disease Trial in Puerto Rico, United States (High dose potent statin, ACE-I (lisinopril) or ARB (losartan),

      Recruiting
      • Coronary Artery Disease
      • High dose potent statin
      • +4 more
      • Mobile, Alabama
      • +83 more
      Sep 14, 2021

      Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention Trial in Nanjing (Placebo plus high-intensity

      Not yet recruiting
      • Acute Coronary Syndrome
      • +3 more
      • Placebo plus high-intensity statin
      • PCSK 9 Inhibitor plus high-intensity statin
      • Nanjing, Jiangsu, China
        Nanjing First Hospital
      Aug 1, 2022

      Acute Coronary Syndrome, Coronary Artery Ectasia Trial in Mexico City (Rivaroxaban 15 MG, Acetylsalicylic acid 100mg,

      Recruiting
      • Acute Coronary Syndrome
      • Coronary Artery Ectasia
      • Rivaroxaban 15 MG
      • +2 more
      • Mexico City, Mexico
      • +1 more
      Jan 31, 2022

      Colorectal Cancer Trial (ME-344, Bevacizumab)

      Not yet recruiting
      • Colorectal Cancer
      • (no location specified)
      Apr 20, 2023

      Type 2 Diabetes, Cardiovascular Risk Factor Trial in Catanzaro (Empagliflozin 10 MG, Glimepiride 2 mg)

      Completed
      • Type 2 Diabetes
      • Cardiovascular Risk Factor
      • Empagliflozin 10 MG
      • Glimepiride 2 mg
      • Catanzaro, Italy
        Universital Hospital Mater Domini
      Jan 14, 2023

      Coronary Artery Disease Trial in Belgium (Colchicine 0.5 MG Oral Tablet, Placebo)

      Not yet recruiting
      • Coronary Artery Disease
      • Colchicine 0.5 MG Oral Tablet
      • Placebo
      • Aalst, Belgium
      • +18 more
      Oct 17, 2023

      Coronary Artery Disease, Peripheral Vascular Disease, Myocardial Infarction Trial in Falls Church (Vorapaxar, Vorapaxar and

      Completed
      Has Results
      • Coronary Artery Disease
      • +2 more
      • Falls Church, Virginia
        Inova Fairfax Hospital
      Jul 22, 2022

      Stroke, Cerebrovascular Accident Trial in Edison (Cardiac rehabilitation program)

      Recruiting
      • Stroke
      • Cerebrovascular Accident
      • Cardiac rehabilitation program
      • Edison, New Jersey
        Hackensack Meridian Health - JFK Johnson Rehabilitation Institut
      Jan 20, 2023

      Patient With Anterior Myocardial Infarction Trial in Sohag (-group of patients(75 patients) will receive low dose rivaroxaban

      Not yet recruiting
      • Patient With Anterior Myocardial Infarction
      • -group of patients(75 patients) will receive low dose rivaroxaban myocardial infarction plus (acetylsalicylic acid 75 mg and clopidogrel 75 mg
      • (acetylsalicylic acid 75 mg once daily orally and clopidogrel 75 mg once daily orally only)
      • Sohag, Egypt
        Sohag University Hospital
      Feb 16, 2023